Seminars in Spine Surgery
Volume 18, Issue 4 , Pages 207-210 , December 2006

Bone Morphogenetic Protein for Pseudarthrosis Repair in Revision Cervical Spine Surgery

  • Andrew P. White, MD

      Affiliations

    • Rothman Institute, Thomas Jefferson University, Philadelphia, PA.
    • ,
  • Richard S. Lee, MD

      Affiliations

    • Orthopaedic Surgery, Yale Department of Orthopaedics and Rehabilitation, New Haven, CT.
    • ,
  • Jonathan N. Grauer, MD

      Affiliations

    • Orthopaedic Surgery, Yale Department of Orthopaedics and Rehabilitation, New Haven, CT.
    • Corresponding Author InformationAddress reprint requests to Jonathan N. Grauer, MD, Associate Professor of Orthopaedic Surgery, Yale Department of Orthopaedics and Rehabilitation, 800 Howard Avenue, New Haven, CT 06511.

References 

  1. Vaccaro AR, Anderson DG, Patel T, et al. Comparison of OP-1 Putty (rhBMP-7) to iliac crest autograft for posterolateral lumbar arthrodesis: a minimum 2-year follow-up pilot study. Spine. 2005;30:2709–2716
  2. Burkus JK, Heim SE, Gornet MK, et al. The effectiveness of rhBMP-2 in replacing autograft: an integrated analysis of three human spine studies. Orthopedics. 2004;27:723–728
  3. Banwart JC, Asher MA, Hassanein RS. Iliac crest bone graft harvest donor site morbidity: a statistical evaluation. Spine. 1995;20:1055–1060
  4. Ebraheim NA, Elgafy H, Xu R. Bone-graft harvesting from iliac and fibular donor sites: techniques and complications. J Am Acad Orthop Surg. 2001;9:210–218
  5. Riew KD, Park JB, Cho KJ, et al. Does BMP-2 hasten anterior cervical fusion?. Spine J. 2005;5:148S
  6. Grauer JN, Vaccaro AR, Kato M, et al. Development of a New Zealand white rabbit model of spinal pseudarthrosis repair and evaluation of the potential role of OP-1 to overcome pseudarthrosis. Spine. 2004;29:1405–1408
  7. Lawrence JP, Waked W, Gillon TJ, et al. rhBMP-2 (ACS and CRM formulations) overcomes pseudarthrosis in a New Zealand white rabbit posterolateral fusion model. Spine. 2006;(in press)
  8. Grauer JN, Patel TC, Erulkar JS, et al. 2000 Young Investigator Research Award winner (Evaluation of OP-1 as a graft substitute for intertransverse process lumbar fusion). Spine. 2001;26:127–133
  9. White AP, Weinstein MA, Patel T, et al. The Marshall Urist Young Investigators Award; Lumbar arthrodesis gene expression, a comparison of autograft with OP-1. Clin Orthop. 2004;429:330–337
  10. White AP, Maak TA, Albert TJ, et al. Gene expression in pseudarthrosis repair by OP-1 or autograft in nicotine exposed rabbit model. Spine. 2006;(in press)
  11. McKay B, Sandhu HS. Use of recombinant bone morphogenetic protein-2 in spinal fusion applications. Spine. 2002;2:21–24
  12. Poynton AR, Lane JM. Safety profile for the clinical use of bone morphogenetic proteins in the spine. Spine. 2002;27:S40–S48
  13. Pradhan BB, Bae HW, Dawson EG, et al. Graft resorption with the use of bone morphogenetic protein: lessons from anterior lumbar interbody fusion using femoral ring allografts and recombinant bone morphogenetic protein-2. Spine. 2006;31:E277–E284
  14. Pradhan BB, Bae HW, Kropf MA, et al. Graft resorption with rhBMP-2 in anterior cervical discectomy and fusion: a radiographic characterization of the effect of rhBMP-2 on structural allografts. Spine J. 2005;5:1S–189S
  15. Baskin DS, Ryan P, Sonntag V, et al. A prospective, randomized, controlled cervical fusion study using recombinant human bone morphogenetic protein-2 with the CORNERSTONE-SR allograft ring and the ATLANTIS anterior cervical plate. Spine. 2003;28:1219–1225
  16. Lanman TH, Hopkins TJ. Early findings in a pilot study of anterior cervical interbody fusion in which recombinant human bone morphogenetic protein-2 was used with poly(l-lactide-co-d,l-lactide) bioabsorbable implants. Neurosurg Focus. 2004;16:E6
  17. Riew KD, Tungsiripat R, Wathanaapishith T, et al. BMP-2 for anterior cervical surgery: does it increase early postoperative swallowing difficulties?. Spine J. 2005;5:44S–45S
  18. Wright M. Use of bone morphogenic protein in anterior cervical fusions. Spine J. 2005;5:45S
  19. Shields LBE, Raque G, Glassman S, et al. Adverse effects associated with high dose recombinant human BMP-2 use in anterior cervical spine fusion. Spine. 2006;31:542–547
  20. Sandhu HS, Anderson DG, Andersson GBJ, et al. Summary statement on safety of bone morphogenetic proteins for spinal fusion. Spine. 2002;27:S39
  21. Sandhu HS, Kanim E, Kabo JM, et al. Effective dose of recombinant bone morphogenetic protein 2 in experimental spinal fusion. Spine. 1996;21:2115–2122
  22. Patel VV, Zhao L, Wong P, et al. Controlling bone morphogenetic protein diffusion and bone morphogenetic protein stimulated bone growth using fibrin glue. Spine. 2006;31:1201–1206
  23. Patel VV, Zhao L, Wong P, et al. An in vitro and in vivo analysis of fibrin glue use to control bone morphogenetic protein diffusion and bone morphogenetic protein stimulated bone growth. Spine J. 2006;6:397–404
  24. Suh DY, Boden SD, Louis-Ugbo J, et al. Delivery of bone morphogenetic protein-2 using a compression-resistant matrix in posterolateral spine fusion in the rabbit and in the non-human primate. Spine. 2002;27:353–360
  25. Morisue H, Matsumoto M, Chiba K, et al. A novel hydroxyapatite fiber mesh as a carrier for recombinant human bone morphogenetic protein-2 enhances bone union in rat posterolateral fusion model. Spine. 2006;31:1194–1200

PII: S1040-7383(06)00070-0

doi: 10.1053/j.semss.2006.09.005

Seminars in Spine Surgery
Volume 18, Issue 4 , Pages 207-210 , December 2006

Article Tools